Skip to main content

Wockhardt gets CDSCO approval to export Sputnik Vaccines

consultant

 

Pharma courses

consultant

 

pharma courses

Wockhardt gets CDSCO nod for exporting up to 100 million doses of Sputnik Vaccines

Wockhardt Limited has received permission from the Central Drugs Standard Control Organization (CDSCO) to export up to 80 million doses of Sputnik Light and up to 20 million doses of Sputnik V Component I vaccine.

Wockhardts Bulk vaccine and Fill-Finish manufacturing facilities at Waluj and Shendra, Aurangabad respectively were jointly inspected and approved by Drug inspectors from CDSCO (West zone) & Aurangabad State FDA and Expert from CDL Kasauli to receive export NOC.

Wockhardt’s state-of-the-art automated manufacturing facilities in Aurangabad are dedicated to produce world class high quality injectable products.

Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against COVID-19 based on the technology transfer from Gamaleya National Research Institute of Epidemiology and Microbiology.


Subscribe to PharmaTutor News Alerts by Email

<< Back to Pharma News

Search this website